ABAXIS Interest Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ABAX Interest Expense Rankings
| Overall | 99th percentile | 31 of 4677 |
| Sector | 98th percentile | 8 of 531 in Healthcare |
| Industry | 94th percentile | 1 of 18 in Diagnostic Substances |
ABAX Interest Expense Range, Past 5 Years
| Minimum | -0.02M | Mar 2001 |
| Maximum | 0.17M | Mar 1999 |
| Average | 0.03M |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
You may also be interested in these ABAX related companies
ABAX News
Canaccord Genuity Reiterates a 'Hold' on Abaxis Inc. (ABAX); Misses on Top and Bottom Lines; Lowering Estimates & PT
Jan 27, 10:19AM Street Insider
Jan 27, 10:19AM Street Insider
Listen to $ABAX Q3 2012 earnings call - live at 04:15 PM, ondemand after - http://stks.co/272d
about 17 days ago by earningscast
about 17 days ago by earningscast
Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2012
Jan 26, 4:00PM PR Newswire
Jan 26, 4:00PM PR Newswire
Abaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Jan 26, 7:45AM PR Newswire
Jan 26, 7:45AM PR Newswire
Abaxis to Report Third Quarter Fiscal Year 2012 Financial Results Thursday, January 26, 2012
Jan 17, 7:00AM PR Newswire
Jan 17, 7:00AM PR Newswire
Canaccord Genuity Starts Abaxis Inc. (ABAX) at Hold; Vet and Medical Markets Show Signs of Stabilizing
Jan 06, 8:55AM Street Insider
Jan 06, 8:55AM Street Insider
Abaxis (ABAX) Veterinary Division Announces Development of Quantitative Lyme Test
Dec 27, 8:03AM Street Insider
Dec 27, 8:03AM Street Insider
Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Dec 27, 8:01AM Benzinga
Dec 27, 8:01AM Benzinga
Abaxis, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
Nov 22, 8:00AM PR Newswire
Nov 22, 8:00AM PR Newswire
Here's some stocks ready for a massive squeeze: $ABAX $CBZ $VIVO $ONCY $INWK & $GHDX to name a few http://stk.ly/jLlrtE
about 248 days ago by SharePlanner
about 248 days ago by SharePlanner
$ABAX http://chart.ly/hkccquu Nice move yest. on strong volume closed near HoD. Setting up to challenge recent highs.
about 341 days ago by TheEquitiesRoom
about 341 days ago by TheEquitiesRoom
$ABAX not like $ebix, neg. volume, higher PE with less growth- be careful
about 347 days ago by akminer
about 347 days ago by akminer
5 Set-ups for Thursday. http://bit.ly/hOcej1 $ABAX $CSX $NSC $MTL $VIT
about 347 days ago by PatternProfits
about 347 days ago by PatternProfits
$ABAX http://chart.ly/e97y5fx Stalking this symm. triangle b/o over $27. High short interest also makes it a squeeze candidate.
about 347 days ago by PatternProfits
about 347 days ago by PatternProfits
$ABAX more shares sold by $SEVERSON CLINTON. See holders at http://tinyurl.com/2bs2nva
about 430 days ago by whalewisdom
about 430 days ago by whalewisdom
$ABAX upgraded from Mkt Perform to Mkt Outperform http://bit.ly/bbuT7e #nasdaq
about 572 days ago by NASDAQ
about 572 days ago by NASDAQ
http://chart.ly/6by5dx $ABAX - RT @Briefingcom Avondale ups to Mkt Outperform // Monthly techs look like bottom rail could be tested.
about 573 days ago by Xiphos_Trading
about 573 days ago by Xiphos_Trading
Trade: CALENDAR on $ABAX: -3 JAN10 25 / +3 MAY10 25 CALLS 2.33 http://bit.ly/7XeDS3
about 777 days ago by dbjret
about 777 days ago by dbjret
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABAX | 27.49 | -0.41 | -1.47% | 595.98M |
| ADVS | 27.23 | -0.44 | -1.59% | 1.38B |
| EBIX | 25.49 | -0.39 | -1.51% | 954.09M |
| NETC | 11.47 | -0.55 | -4.58% | 1.31B |
| CTCT | 30.63 | 0.22 | 0.72% | 910.94M |
| PETS | 12.08 | -0.04 | -0.33% | 245.71M |
| TLEO | 45.66 | 0.01 | 0.03% | 1.89B |
| MOLX | 27.30 | -0.40 | -1.44% | 4.80B |
| MENT | 14.49 | -0.25 | -1.70% | 1.59B |
| SMSC | 26.97 | -0.22 | -0.81% | 615.19M |
